Tissue Repair Ltd (TRP.AX)

0.2450 0.0000 (0.00%) At close: 03:21PM AEST

Tissue Repair Ltd

255 Pitt Street
Level 10
Sydney, NSW 2000
Australia
61 427 985 805
https://www.tissuerepair.com.au

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Tony Charara	Co-Founder & Executive Director	100k	N/A	N/A
Mr. Cameron Jones C.A.	Chief Financial Officer	N/A	N/A	N/A
Dr. Darryl Reed	Chief Operating Officer	N/A	N/A	N/A
Ms. Sushma Kejriwal	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Tissue Repair Ltd, a clinical stage biopharmaceutical company, developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures, as well as other products for veterinary, new bandage, scaffold products, and other therapeutic indications. The company was incorporated in 2012 and is headquartered in Sydney, Australia.

Corporate governance

Tissue Repair Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.